Dr. Georgios Katsipis holds a PhD in Biochemistry from the Aristotle University of Thessaloniki (AUTh) and is a Postdoctoral Researcher in the Laboratory of Neurodegenerative Diseases (LND) of the Center for Interdisciplinary Research and Innovation (CIRI). His research focuses on the analysis of biomarkers for the diagnosis and treatment of Alzheimer's disease (AD) and mild cognitive impairment (MCI), as well as the involvement of inflammation and infections in the onset of neurodegenerative diseases. He has established an in vitro model of AD neuroinflammatory pathology based on primary neuron-glia cells isolated from rat brains. He has participated in two funded research projects concerning the beneficial effects of physical exercise in patients with early dementia and the analysis of inflammatory biomarkers and microbial infections in Alzheimer's patients. Additionally, he has researched the anti-inflammatory and antimicrobial properties of natural products in rat primary neuron-glia cultures and neuronal cancer cells. Results from these studies have highlighted, for the first time, the potential of involving bacterial metabolites (lipopolysaccharides, flagellin, etc.) in the diagnosis of Alzheimer’s disease, while also promoting the employment of non-intervention diagnosis, i.e., saliva and blood analysis. He is also involved in in vivo studies for the effect of induced-inflammation on rat models of Alzheimer’s disease.
Dr. Georgios Katsipis holds a PhD in Biochemistry from the Aristotle University of Thessaloniki (AUTh) and is a Postdoctoral Researcher in the Laboratory of Neurodegenerative Diseases (LND) of the Center for Interdisciplinary Research and Innovation (CIRI). His research focuses on the analysis of biomarkers for the diagnosis and treatment of Alzheimer's disease (AD) and mild cognitive impairment (MCI), as well as the involvement of inflammation and infections in the onset of neurodegenerative diseases. He has established an in vitro model of AD neuroinflammatory pathology based on primary neuron-glia cells isolated from rat brains. He has participated in two funded research projects concerning the beneficial effects of physical exercise in patients with early dementia and the analysis of inflammatory biomarkers and microbial infections in Alzheimer's patients. Additionally, he has researched the anti-inflammatory and antimicrobial properties of natural products in rat primary neuron-glia cultures and neuronal cancer cells. Results from these studies have highlighted, for the first time, the potential of involving bacterial metabolites (lipopolysaccharides, flagellin, etc.) in the diagnosis of Alzheimer’s disease, while also promoting the employment of non-intervention diagnosis, i.e., saliva and blood analysis. He is also involved in in vivo studies for the effect of induced-inflammation on rat models of Alzheimer’s disease.